Royalty Pharma offers to buy Elan for about $6.5B

Home › Royalty Pharma offers to buy Elan for about $6.5B

Royalty Pharma said Monday that it wants to buy Elan for about $6.5 billion, but has yet to receive a formal response from the Irish drugmaker.

21.09	Atlantic Tropical Weather Outlook
21.09	Eastern North Pacific Tropical Weather Outlook
20.09	Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09	September Cattle on Feed as expected
20.09	USDA announces major investment in meat and poultry processing
20.09	Atlantic Tropical Weather Outlook
20.09	Eastern North Pacific Tropical Weather Outlook
20.09	This weeks lesson: Weaning matters in the cattle market
More »

je.st